PhD scholarship recipients

The Leukaemia Foundation and HSANZ are helping more medical and science graduates pursue a research career in blood cancer by co-funding PhD scholarships.

Find out more about the research projects our current PhD Scholarship recipients are working on.

2024 recipients

Dr Helen Cashman

Understanding why some Lymphomas are resistant to CAR-T therapy

Dr Eric Wenlong Li

Improving treatment of blood cancers using targeted therapies

Damien D’Silva

Advancing the effective use of targeted therapies for blood cancers while reducing side effects

2023 recipients

Dr Jessica Elliott

T-cell versus T-cell biology: mechanisms and modulation of disease and therapy

Dr Sun Loo

Treatment of acute myeloid leukaemia at the timepoint when small amounts of leukaemia cells are detected to prevent advanced disease

2022 recipients

Dr Ray Koo

Improving outcomes for patients after donated stem cell transplants

DR RAY KOO: Improving outcomes for patients after donated stem cell transplants

Dr Jasmine Singh

Clonal haematopoiesis of indeterminate potential (CHIP) – what does it mean?

DR JASMINE SINGH: Investigating the effect of aspirin on genetic risk factors for blood cancer

Dr Vajiranee Malalasekera

Investigating mechanisms of disease development and new therapies in AML with high-risk genetic alternations

2021 recipients

Basit Salik

Targeting the cancer-immune crosstalk in AML

Dr Julian Grabek

Identifying subclones in early phase MPN that drive progression and leukaemic transformation

2020 recipients

Dr Liesl Butler

Investigating the gene mutations and biological pathways that lead to the development of MPNs

Development of improved biomarkers and targeted therapies for MPN

Liesl-Butler-PhD-Scholarship-2019-Blood-Cancer

Dr Khai Li Chai

Evaluating the evidence base, current practice and clinical outcomes of immunoglobulin treatment

Julian Lindsay

Using antifungal treatments to prevent infection in people with blood cancers and those undergoing bone marrow transplants

PhD project archive

2019

Dr Wei Jiang – T-cell immunotherapy for B-cell malignancies and viral infections

Dr Karthik Nath – Using genetic and molecular technologies to better understand follicular lymphoma

Elizabeth Lieschke – Investigating the mechanisms by which Tp53 prevents the development of leukaemia, lymphoma

Last updated on November 13th, 2023

Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.